AI assistant
Sarepta Therapeutics, Inc. — Director's Dealing 2021
Mar 11, 2021
31721_dirs_2021-03-10_78edab76-bfef-4cee-b2e8-9ba42d4923d9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2021-02-28
Reporting Person: Estepan Ian Michael (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-28 | Common Stock | F | 319 | $86.97 | Disposed | 13723 | Direct |
| 2021-03-03 | Common Stock | A | 15000 | $0.00 | Acquired | 28723 | Direct |
| 2021-03-05 | Common Stock | F | 347 | $84.65 | Disposed | 28376 | Direct |
Footnotes
F1: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020.
F2: On March 5, 2021, the Form 4 filed for the reporting person overstated the number of shares held by the reporting person. This amended form corrects such error by reporting the number of shares withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units on February 28, 2021 and by reporting the corrected total amount of securities directly owned by the reporting person following a grant of restricted stock units on March 3, 2021.
F3: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 5, 2018.